Pulse Medical

Pulse Medical Imaging Technology is a Shanghai-based medtech company specializing in computational functional imaging for cardiovascular diagnosis. The company's core innovation is the Quantitative Flow Ratio (QFR) technology, which enables the physiological assessment of coronary artery disease using standard angiographic images, eliminating the need for invasive pressure wires or hyperemic agents. Their product portfolio, including the AngioPlus system, integrates artificial intelligence to provide rapid, wire-free fractional flow reserve (FFR) measurements during catheterization procedures. Pulse Medical's solutions are designed to optimize percutaneous coronary intervention (PCI) workflows and improve patient outcomes through precision diagnostics. The company has established a strong clinical evidence base through the FAVOR trial series and holds regulatory clearances in major markets including China and Europe.